Boehringer Ingelheim

Create an alert
to follow the executive moves at Boehringer Ingelheim.

Most searched biographies at Boehringer Ingelheim

• Hubertus von Baumbach, Chairman of the Management Board
• Michael Schmelmer, Member of the Board of Managing Directors, Fina...
• Michel Pairet, Member of the Management Board, Innovation Unit

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about Boehringer Ingelheim

Boehringer Ingelheim is committed to joining forces in the global fight against rabies | boehringer-ingelheim.com
New vaccine against Bovine Respiratory Disease | boehringer-ingelheim.com
NSCLC treatment sequencing survey | Press
Lume Meso Phase III Results | Press
Boehringer Ingelheim acquires ViraTherapeutics shares | Press

Boehringer Ingelheim on Wikipedia, Google News & Yahoo Finance

Boehringer Ingelheim on LinkedIn, Twitter & YouTube

Boehringer Ingelheim has 18 subsidiaries including Boehringer Ingelheim Animal Health, Boehringer Ingelheim Animal Health USA and Boehringer Ingelheim Belgium. Boehringer Ingelheim has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).

Contact by email its executives including Michael Schmelmer

Call Boehringer Ingelheim at +49....

View the org chart

Register to receive your alert

Report an error